NCT02600130View on ClinicalTrials.gov

Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 10, 2016

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2021

Conditions
Alzheimer's Disease
Interventions
BIOLOGICAL

Longeveron Mesenchymal Stem Cells

via peripheral intravenous infusion

BIOLOGICAL

Placebo

via peripheral intravenous infusion

Trial Locations (3)

33136

University of Miami Miller School of Medicine, Miami

33137

Miami Jewish Health, Miami

33445

Brain Matters Research, Delray Beach

Sponsors

Lead Sponsor

Longeveron Inc.
All Listed Sponsors
lead

Longeveron Inc.

INDUSTRY

NCT02600130 - Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease | Biotech Hunter | Biotech Hunter